RNAi-mediated silencing of CD147 inhibits tumor cell proliferation, invasion and increases chemosensitivity to cisplatin in SGC7901 cells in vitro

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Wang, Bo ^a   Xu, Yong Fei ^a   He, Bang Shun ^b   Pan, Yu Qin ^b   Zhang, Li Rong ^b   Zhu, Chan ^a   Qu, Li Li ^b   Wang, Shu Kui ^b  

^a NANJING NORMAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD147 ANTIGEN; CISPLATIN; GELATIN; GELATINASE A; GELATINASE B; SHORT HAIRPIN RNA; TETRAZOLIUM; ANTINEOPLASTIC AGENT; BSG PROTEIN, HUMAN; MESSENGER RNA; MMP2 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ARTICLE; ASSAY; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL PROLIFERATION; CHEMOSENSITIVITY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STOMACH CANCER; TUMOR GROWTH; WESTERN BLOTTING; ZYMOGRAPHY; APOPTOSIS; CELL ADHESION; CELL MOTION; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; STOMACH TUMOR; TUMOR CELL CULTURE;

ANTIGENS, CD147; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CISPLATIN; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 77952969188     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-61     Document Type: Article

References (27)

1. Cancer statistics, 1997. SL Parker T Tong S Bolden PA Wingo, CA Cancer J Clin 1997 47 5 27 10.3322/canjclin.47.1.5 8996076
2. Cancer burden in the year 2000. The global picture. DM Parkin FI Bray SS Devesa, Eur J Cancer 2001 37 Suppl 8 4 S66 10.1016/S0959-8049(01)00267-2 11602373
3. International variation. DM Parkin, Oncogene 2004 23 6329 6340 10.1038/sj.onc.1207726 15322508
4. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Y Tang P Kesavan MT Nakada L Yan, Mol Cancer Res 2004 2 73 80 14985463
5. Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. H Kataoka R DeCastro S Zucker C Biswas, Cancer Res 1993 53 3154 3158 8319225
6. Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. K Nabeshima H Iwasaki K Koga H Hojo J Suzumiya M Kikuchi, Pathol Int 2006 56 359 367 10.1111/j.1440-1827.2006.01972.x 16792544
7. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Y Tang MT Nakada P Kesavan F McCabe H Millar P Rafferty P Bugelski L Yan, Cancer Res 2005 65 3193 3199 15833850
8. Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway. Y Tang MT Nakada P Rafferty J Laraio FL McCabe H Millar M Cunningham LA Snyder P Bugelski L Yan, Mol Cancer Res 2006 4 371 377 10.1158/1541-7786.MCR-06-0042 16778084
9. Regulation of multidrug resistance in cancer cells by hyaluronan. S Misra S Ghatak A Zoltan-Jones BP Toole, J Biol Chem 2003 278 25285 25288 10.1074/jbc.C300173200 12738783
10. Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. JM Yang Z Xu H Wu H Zhu X Wu WN Hait, Mol Cancer Res 2003 1 420 427 12692261
11. Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production. EA Marieb A Zoltan-Jones R Li S Misra S Ghatak J Cao S Zucker BP Toole, Cancer Res 2004 64 1229 1232 10.1158/0008-5472.CAN-03-2832 14983875
12. Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis. HC Zheng H Takahashi Y Murai ZG Cui K Nomoto S Miwa K Tsuneyama Y Takano, Br J Cancer 2006 95 1371 1378 10.1038/sj.bjc.6603425 17088917
13. A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma. X Chen J Lin T Kanekura J Su W Lin H Xie Y Wu J Li M Chen J Chang, Cancer Res 2006 66 11323 11330 10.1158/0008-5472.CAN-06-1536 17145878
14. CD147 interactions with cyclophilins. V Yurchenko S Constant M Bukrinsky, Immunology 2006 117 301 309 10.1111/j.1365-2567.2005.02316.x 16476049
15. A system for stable expression of short interfering RNAs in mammalian cells. TR Brummelkamp R Bernards R Agami, Science 2002 296 550 553 10.1126/science.1068999 11910072
16. Silencing CD147 inhibits tumor progression and increases chemosensitivity in murine lymphoid neoplasm P388D1 cells. L Jia W Wei J Cao H Xu X Miao J Zhang, Ann Hematol 2009 88 753 760 10.1007/s00277-008-0678-2 19125248
17. Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. M Li Q Zhai U Bharadwaj H Wang F Li WE Fisher C Chen Q Yao, Cancer 2006 106 2284 2294 10.1002/cncr.21862 16604531
18. Axis of evil: molecular mechanisms of cancer metastasis. T Bogenrieder M Herlyn, Oncogene 2003 22 6524 6536 10.1038/sj.onc.1206757 14528277
19. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. P Vihinen VM Kahari, Int J Cancer 2002 99 157 166 10.1002/ijc.10329 11979428
20. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. EE Gabison T Hoang-Xuan A Mauviel S Menashi, Biochimie 2005 87 361 368 10.1016/j.biochi.2004.09.023 15781323
21. Combined transcriptome and genome analysis of single micrometastatic cells. CA Klein S Seidl K Petat-Dutter S Offner JB Geigl O Schmidt-Kittler N Wendler B Passlick RM Huber G Schlimok PA Baeuerle G Riethmuller, Nat Biotechnol 2002 20 387 392 10.1038/nbt0402-387 11923846
22. Tumorigenic potential of extracellular matrix metalloproteinase inducer. S Zucker M Hymowitz EE Rollo R Mann CE Conner J Cao HD Foda DC Tompkins BP Toole, Am J Pathol 2001 158 1921 1928 11395366
23. CD147 immunoglobulin superfamily receptor function and role in pathology. KT Iacono AL Brown MI Greene SJ Saouaf, Exp Mol Pathol 2007 83 283 295 10.1016/j.yexmp.2007.08.014 17945211
24. Involvement of CD147 in regulation of multidrug resistance to P-gp substrate drugs and in vitro invasion in breast cancer cells. QQ Li WJ Wang JD Xu XX Cao Q Chen JM Yang ZD Xu, Cancer Sci 2007 98 1064 1069 10.1111/j.1349-7006.2007.00487.x 17441962 (Pubitemid 46865392)
25. Up-regulation of CD147 and matrix metalloproteinase-2,-9 induced by P-glycoprotein substrates in multidrug resistant breast cancer cells. QQ Li WJ Wang JD Xu XX Cao Q Chen JM Yang ZD Xu, Cancer Sci 2007 98 1767 1774 10.1111/j.1349-7006.2007.00593.x 17725804 (Pubitemid 47487914)
26. Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910pm cells. W Zou H Yang X Hou W Zhang B Chen X Xin, Cancer Lett 2007 248 211 218 10.1016/j.canlet.2006.07.005 16930823
27. RNA interference targeting the CD147 induces apoptosis of multi-drug resistant cancer cells related to XIAP depletion. YH Kuang X Chen J Su LS Wu LQ Liao D Li ZS Chen T Kanekura, Cancer Lett 2009 276 189 195 10.1016/j.canlet. 2008.11.010 19097686